Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Stryker, OrthoSensor announce co-marketing agreement

Stryker Corporation’s Orthopaedics division and OrthoSensor, a provider of intelligent orthopedics, have announced an extension of their co-marketing agreement for Stryker’s Triathlon Knee System and OrthoSensor’s Verasense.

OrthoSensor’s Verasense is an intelligent, low-cost, single-use instrument system that replaces the standard plastic tibial trial spacer used during knee replacement surgery.

Utilising advanced proprietary sensor and communications technologies, Verasense gives surgeons real-time feedback on soft tissue balance during knee-replacement surgery. With the help of quantitative data, surgeons can make informed, evidence-based adjustments to the soft tissues and implant placement.

The Triathlon Knee System is designed to promote ligament balance through the active range of motion to enhance stability and mobility, even during mid-flexion1-6.

Stryker Orthopaedics knee reconstruction vice president and general manager Patrick Treacy said that the single radius design philosophy of Stryker knees is a perfect complement to OrthoSensor’s innovative technology.

"The Triathlon Knee System is suited to the finer elements of ligament balancing and being able to take advantage of this new offering provides us with the opportunity to combine our advanced orthopaedic implant technology with innovative sensor technology," Treacy added.

OrthoSensor CEO Jay Pierce said that Verasense provides surgeons with intraoperative data to quantify and verify that they balance a knee implant during total knee arthroplasty.

"By enabling surgeons to make evidence-based, intraoperative decisions, we can help improve patient care, measure clinical outcomes and help lower the cost of treating musculoskeletal disease," Pierce added.